Skip to content

CeriBell, Inc. CBLL Operating Cash Flow

Operating Cash Flow at other companies

IAR
Integra LifeSciencesIART
$9.8M+187%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$7.97M-29.1%
iRadimed logo
iRadimedIRMD
$8.29M+93.2%
Teladoc Health logo
Teladoc HealthTDOC
$9.52M-40.2%
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
-$18.37M-2.1%
Cerence Inc. logo
Cerence Inc.CRNC
$14.11M-8.8%

Other financials

Income statement

See full
Revenue$26.5M+29.3%
Gross profit$23.1M+28.4%
Operating income-$20.7M-46.0%
Net income-$19.7M-54.5%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$45.3M-70.5%
Total debt$22.1M+1.6%
Total equity$140.8M-22.2%
Total assets$178.1M-16.6%

Cash flow

See full
CapEx$125.0K-15.5%
Free cash flow-$19.4M-68.1%

Valuation

See full
Market cap$748.61M+15.6%
Enterprise value$725.47M+40.7%
P/S7.9×-1.2×

Profitability

See full
Gross margin87.7%+0.5pp
Operating margin-68.3%+5.5pp
Net margin-63.5%+1.0pp
FCF margin-52%-1.4pp

Returns & leverage

See full
Return on equity-37.5%
Debt / equity0.2×0.0×
Current ratio10.4×-6.9×

Where this comes from

Reported directly by CeriBell, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: CeriBell, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about CeriBell, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CeriBell, Inc.'s operating cash flow?
CeriBell, Inc. (CBLL) reported operating cash flow of -$19.3M in Q1 2026.
How has CeriBell, Inc.'s operating cash flow changed year-over-year?
CeriBell, Inc.'s operating cash flow decreased by 69.2% year-over-year, from -$11.4M to -$19.3M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.